Brought to you by 
Fluidigm adds single-cell analysis tools through $207.5mm DVS takeover
31 Jan 2014
Executive Summary
Fluidigm Corp. (microfluidics systems) acquired closely held flow cytometry company DVS Sciences Inc. for $207.5mm, consisting of $125mm in cash (most of which was generated from Fluidigm’s concurrently announced $170mm convertible notes offering) and $82.5mm in Fluidigm shares (approximately 2mm based on the market average).
Deal Industry
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Fluidigm adds single-cell analysis tools through $207.5mm DVS takeover
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice